New Glaucoma Drug Begins Clinical Trials

NurExone's ExoPTEN Being Studied as Glaucoma Treatment for

Ygal Rotenstreich and Dr. Ifat Sher from the Sheba Medical Center Eye Institute1, is the latest step in expanding potential clinical indications ...

Corporate news details - Bristol Myers Squibb

U.S. Food and Drug Administration Approves Bristol Myers Squibb's COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic ...

Clinical Trials | Bascom Palmer Eye Institute | University of Miami ...

Clinical trials offer new hope for treating eye diseases. Discover the ... Search Ongoing Clinical Trials by Specialty. Cornea Glaucoma Ophthalmology ...

2024 Will See Major Advances in Glaucoma Care - Medscape

Microshunts inserted into the eye also have been used to reduce IOP. An early stage study is evaluating a new-generation, minimally invasive ...

Skye ends eye disease R&D after glaucoma drug's phase 2 fail

“With this data outcome from our glaucoma program, we will now focus 100% of our efforts on broadening our metabolic clinical pipeline,” Dhillon ...

Sustained-delivery Glaucoma Treatments

The iDose is designed to deliver long-duration drug therapy, though in clinical studies, the IOP-lowering effect was found to last out to 36 ...

Large clinical study on promising potential glaucoma treatment to ...

In the spring of 2022, researchers at Umeå University, Karolinska Institutet, and St. Erik Eye Hospital will begin a large clinical study on ...

Glaucoma vitamin B3 trial | CERA - Centre for Eye Research Australia

Research to determine if vitamin B3 can treat optic nerve damage caused by glaucoma is entering its next phase with a new trial set to begin ...

Challenging the "Topical Medications-First” Approach to Glaucoma

Following upon SLT and MIGS, SRDD's are the newest entry into the glaucoma treatment space. As a class they aim to provide the benefits of ...

AI Used to Advance Drug Delivery System for Glaucoma and Other ...

Published May 2 in Nature Communications, the new research showed that artificial intelligence-designed models accurately predicted an ...

Can Nutrient Supplements Prevent Glaucoma?

We just conducted a small clinical trial here—led by Carlos Gustavo De Moraes, Jack Cioffi, and Jeffrey Liebmann—and the results are very ...

Clinical trials - Gene Vision

The intervention tested can either be a new drug, a device, a procedure or even changes to a participants' behaviour (such as dieting). It is ...

Brimonidine Ophthalmic: MedlinePlus Drug Information

Ophthalmic brimonidine is used to lower pressure in the eyes in patients who have glaucoma (high pressure in the eyes that may damage nerves and cause vision ...

What's New in the Glaucoma Drug and Surgical Device Pipeline for ...

Over a 1 year course of clinical trials, the implant maintained stable and sustained IOP reductions without serious adverse events. The creators ...

A potential primary endpoint for clinical trials in glaucoma ... - Nature

Intraocular pressure (IOP) reduction significantly slows the rate of visual field progression for all glaucoma subtypes and across the disease ...

Newer advances in medical management of glaucoma

Newer advances in medical management of glaucoma · Abstract · Rho Kinase Inhibitors · Latanoprostene Bunod · Newer Drug Delivery Systems · Investigational Glaucoma ...

Clinical Trials for Eye Diseases and Vision - Prevent Blindness

... new treatment or therapy. You typically do not pay for services directly related to the clinical trial after you have been accepted. You may incur personal ...

New treatments and surgeries are transforming the glaucoma ...

Historically, topical medications have been considered the first-line treatment for patients with glaucoma. There are now 5 major categories of ...

Glaucoma Fort Worth | Research - Ophthalmology Associates

Patients may choose to participate in studies on new medications, new methods of administering medication to avoid the need for eyedrops, and minimally invasive ...

For Hughes Family, All Eyes on Glaucoma Research

Tanna confirmed Mr. Hughes's glaucoma diagnosis and started him on a treatment regimen to lower the pressure in his eyes. Eye drop medications ...